Drug Type DC-CTL Therapy |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Clinical | - | 11 Mar 2025 | |
| Colorectal Cancer | Clinical | - | 11 Mar 2025 | |
| Esophageal Carcinoma | Clinical | - | 11 Mar 2025 | |
| Liver Cancer | Clinical | - | 11 Mar 2025 | |
| Lung Cancer | Clinical | - | 11 Mar 2025 | |
| Solid tumor | Clinical | China | - |





